Last Week Of Fun In The Markets? Click to watch.

Dynavax Technologies Corporation Stock Forecast

NASDAQ:DVAX BUY SELL

$12.59 (-1.56%)

Volume: 1.107M

Closed: Jun 30, 2022

Hollow Logo Score: 4.103

Dynavax Technologies Corporation Stock Forecast

BUY SELL NASDAQ:DVAX
$12.59 (-1.56%)

Volume: 1.107M

Closed: Jun 30, 2022

Score Hollow Logo 4.103

DVAX Price Targets and Analyst Ratings NASDAQ:DVAX

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2021-12-29 122.4% HC Wainwright & Co. $23.00 $28.00 Maintains Buy
2021-08-31 82.68% HC Wainwright & Co. $20.00 $23.00 Maintains Buy
2021-08-06 50.91% Goldman Sachs $19.00 Initiates Coverage On Buy
2021-08-05 58.86% HC Wainwright & Co. $16.00 $20.00 Maintains Buy
2021-02-01 19.14% HC Wainwright & Co. $14.00 $15.00 Maintains Buy
2020-11-06 11.2% HC Wainwright & Co. $12.00 $14.00 Maintains Buy
2020-08-07 -4.69% HC Wainwright & Co. $14.00 $12.00 Maintains Buy
2020-08-03 11.2% HC Wainwright & Co. $12.00 $14.00 Maintains Buy
2020-03-12 -4.69% HC Wainwright & Co. $13.00 $12.00 Reiterates Buy
2019-10-18 3.26% HC Wainwright & Co. $13.00 Initiates Coverage On Buy
2019-07-11 - Cantor Fitzgerald - Upgrades Neutral Overweight

DVAX Stock Trend

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $13.39 will firstly indicate a stronger rate of rising.

Given the current short-term trend, the stock is expected to rise 19.36% during the next 3 months and, with a 90% probability hold a price between $10.31 and $15.98 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-07-05 $8.68 $11.05 $13.43
2022-07-06 $8.71 $11.09 $13.46
2022-07-07 $8.75 $11.12 $13.50
2022-07-08 $8.78 $11.16 $13.53
2022-07-11 $8.82 $11.19 $13.57
2022-07-12 $8.85 $11.23 $13.60
2022-07-13 $8.89 $11.26 $13.64
2022-07-14 $8.92 $11.30 $13.67
2022-07-15 $8.96 $11.33 $13.71
2022-07-18 $8.99 $11.37 $13.74
2022-07-19 $9.03 $11.40 $13.78
2022-07-20 $9.06 $11.44 $13.81
2022-07-21 $9.10 $11.47 $13.85
2022-07-22 $9.13 $11.51 $13.88
2022-07-25 $9.17 $11.54 $13.92
2022-07-26 $9.20 $11.58 $13.95
2022-07-27 $9.24 $11.61 $13.99
2022-07-28 $9.27 $11.65 $14.02
2022-07-29 $9.31 $11.68 $14.06
2022-08-01 $9.34 $11.72 $14.09
2022-08-02 $9.38 $11.75 $14.13
2022-08-03 $9.41 $11.79 $14.16
2022-08-04 $9.45 $11.82 $14.20
2022-08-05 $9.48 $11.86 $14.23
2022-08-08 $9.52 $11.89 $14.27
2022-08-09 $9.55 $11.93 $14.30
2022-08-10 $9.59 $11.96 $14.34
2022-08-11 $9.62 $12.00 $14.37
2022-08-12 $9.66 $12.03 $14.41
2022-08-15 $9.69 $12.07 $14.44

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 541 stocks, only a few dozen will trigger such a signal!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. Its development programs focuses on vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company’s lead products include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, a C Class CpG TLR9 agonist for... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT